1

KEI Statement on India’s granting of compulsory license to patents on cancer drug sorafenib (NATCO Vs. BAYER)

The India Controller General Controller General of Patents, Designs & Trade Marks has just (March 12, 2012) issued an order granting a compulsory license to patents on the cancer drug sorafenib/Nexavar, in the matter of NATCO Vs. BAYER. A copy of the decision is attached below.

Continue Reading

CCIA proposes alternative text for TPPA, but proposals do not address many problems in the text

The Computer & Communications Industry Association (CCIA) recently made proposals for what it considers to be necessary “to make the Internet work” in the Trans-Pacific Partnership Agreement. The proposals put forth either as additions or alternatives to some of what the US has tabled are, in general, a step in the right direction as they seek to improve copyright exceptions and limit liability. Continue Reading

Uncategorized

ACTA: US Intervention on IP Enforcement Trends at WTO Council for TRIPS (28 February 2012)

These are the interventions delivered by the United States of America on 28 February 2012 during WTO Council for TRIPS discussions on ACTA under “IP Enforcement Trends”.

N. IP ENFORCEMENT TRENDS

[U.S. First Intervention]

• We appreciate this opportunity to discuss enforcement of IP rights, and hopefully to dispel some misperceptions about IP enforcement in general and the ACTA in particular.

• Effective enforcement of intellectual property rights is critical to sustaining economic growth across all industries and globally.

Continue Reading

Uncategorized